Citations (43)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Petra Stute. (2021) Dydrogesterone indications beyond menopausal hormone therapy: an evidence review and woman’s journey. Gynecological Endocrinology 37:8, pages 683-688.
Read now
Read now
Hisham Arab, Ahmed Jaber Alharbi, Ayman Oraif, Emad Sagr, Hana Al Madani, Hassan Abduljabbar, Osama Sadeak Bajouh, Yaser Faden & Yasser Sabr. (2019) The Role Of Progestogens In Threatened And Idiopathic Recurrent Miscarriage. International Journal of Women's Health 11, pages 589-596.
Read now
Read now
Nancy Noyola-Martínez, Ali Halhali & David Barrera. (2019) Steroid hormones and pregnancy. Gynecological Endocrinology 35:5, pages 376-384.
Read now
Read now
H. J. A. Carp. (2018) Progestogens and pregnancy loss. Climacteric 21:4, pages 380-384.
Read now
Read now
Nilesh Trivedi, Naveen Chauhan & Vishal Vaidya. (2016) Effectiveness and safety of dydrogesterone in regularization of menstrual cycle: a post-marketing study. Gynecological Endocrinology 32:8, pages 667-671.
Read now
Read now
Natalia Podzolkova, Tetiana Tatarchuk, Aikerm Doshchanova, Gulsara Eshimbetova & Claire Pexman-Fieth. (2016) Dydrogesterone treatment for menstrual-cycle regularization in routine clinical practice: a multicenter observational study. Gynecological Endocrinology 32:3, pages 246-249.
Read now
Read now
Nasrin Saharkhiz, Marzieh Zamaniyan, Saghar Salehpour, Shahrzad Zadehmodarres, Sedighe Hoseini, Leila Cheraghi, Samira Seif & Nafiseh Baheiraei. (2016) A comparative study of dydrogesterone and micronized progesterone for luteal phase support during in vitro fertilization (IVF) cycles. Gynecological Endocrinology 32:3, pages 213-217.
Read now
Read now
Fadi Ghazi Mirza, Ameet Patki & Claire Pexman-Fieth. (2016) Dydrogesterone use in early pregnancy. Gynecological Endocrinology 32:2, pages 97-106.
Read now
Read now
Articles from other publishers (35)
Kai Chen, Xiaoxia Liu, Xianhua Meng, Hui Li, Chenchen Yang & Xiaohong Wang. (2023) Efficacy and safety of Gushen Antai Pills combined with dydrogesterone in the treatment of threatened miscarriage: a systematic review and meta-analysis. Frontiers in Pharmacology 14.
Crossref
Crossref
Kamaludin Dingle, Osama M. Kassem, Fawaz Azizieh, Ghadeer AbdulHussain & Raj Raghupathy. (2023) Quantitative analyses of cytokine profiles reveal hormone-mediated modulation of cytokine profiles in recurrent spontaneous miscarriage. Cytokine 164, pages 156160.
Crossref
Crossref
Nana Tetruashvili, Alice Domar & Asher Bashiri. (2023) Prevention of Pregnancy Loss: Combining Progestogen Treatment and Psychological Support. Journal of Clinical Medicine 12:5, pages 1827.
Crossref
Crossref
Jiazhen Wang, Xin Liu, Yougang Zhang, Shenghua Lin, Honglin Ma, Ting Lei, Chen Sun, Kechun Liu & Qiuxia He. (2023) The Potential Mechanism of Zishen Yutai Pills against Threatened Abortion: An Approach Involving Network Pharmacology and Experimental Evidence. Evidence-Based Complementary and Alternative Medicine 2023, pages 1-16.
Crossref
Crossref
Tatyana V. Rachenkova & Yuliia A. Dudareva. (2023) Predictors of late spontaneous miscarriage: new aspects of an old problem: A review. Gynecology 24:6, pages 451-457.
Crossref
Crossref
Stephanie Pildner von Steinburg, Ekkehard Schleußner, Ruben Kuon, Kilian Vomstein & Bettina Toth. 2023. The Placenta. The Placenta
219
242
.
Xiao Liang, Siling Tang, Dandan Li, Yajing Song, Ming He, Yancang Duan & Huilan Du. (2022) Shoutai Wan Improves Embryo Survival by Regulating Aerobic Glycolysis of Trophoblast Cells in a Mouse Model of Recurrent Spontaneous Abortion. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-17.
Crossref
Crossref
Raj Raghupathy. (2022) Cytokines and pregnancy complications: modulation for prevention and treatment. Exploration of Immunology, pages 414-427.
Crossref
Crossref
Jeffrey K Aronson. (2022) When I use a word . . . . Counterfactual medical history: the death of Charles II. BMJ, pages o1345.
Crossref
Crossref
Raj Raghupathy & Julia Szekeres-Bartho. (2022) Progesterone: A Unique Hormone with Immunomodulatory Roles in Pregnancy. International Journal of Molecular Sciences 23:3, pages 1333.
Crossref
Crossref
Marie-Pierre Piccinni, Raj Raghupathy, Shigeru Saito & Julia Szekeres-Bartho. (2021) Cytokines, Hormones and Cellular Regulatory Mechanisms Favoring Successful Reproduction. Frontiers in Immunology 12.
Crossref
Crossref
Arri Coomarasamy, Rima K Dhillon-Smith, Argyro Papadopoulou, Maya Al-Memar, Jane Brewin, Vikki M Abrahams, Abha Maheshwari, Ole B Christiansen, Mary D Stephenson, Mariëtte Goddijn, Olufemi T Oladapo, Chandrika N Wijeyaratne, Debra Bick, Hassan Shehata, Rachel Small, Phillip R Bennett, Lesley Regan, Raj Rai, Tom Bourne, Rajinder Kaur, Oonagh Pickering, Jan J Brosens, Adam J Devall, Ioannis D Gallos & Siobhan Quenby. (2021) Recurrent miscarriage: evidence to accelerate action. The Lancet 397:10285, pages 1675-1682.
Crossref
Crossref
Sanjana Rajgopal & Raj Raghupathy. (2020) Using the Immune System to Manage Immunologically-Mediated Pregnancy Loss. Annals of the National Academy of Medical Sciences (India) 57:01, pages 08-15.
Crossref
Crossref
Y.Sheena Mary & Y.Shyma Mary. (2021) Utilization of doped/undoped graphene quantum dots for ultrasensitive detection of duphaston, a SERS platform. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 244, pages 118865.
Crossref
Crossref
Narmada Katakam & Luciano G. Nardo. 2021. Progestogens in Obstetrics and Gynecology. Progestogens in Obstetrics and Gynecology
69
82
.
Daniel Mayrhofer, Marlene Hager, Katharina Walch, Stefan Ghobrial, Nina Rogenhofer, Rodrig Marculescu, Rudolf Seemann & Johannes Ott. (2020) The Prevalence and Impact of Polycystic Ovary Syndrome in Recurrent Miscarriage: A Retrospective Cohort Study and Meta-Analysis. Journal of Clinical Medicine 9:9, pages 2700.
Crossref
Crossref
Ming Yang, Jianghe Luo, Yan Li & Limian Xu. (2020) Systems Pharmacology-Based Research on the Mechanism of Tusizi-Sangjisheng Herb Pair in the Treatment of Threatened Abortion. BioMed Research International 2020, pages 1-15.
Crossref
Crossref
Shafat Ali, Sabhiya Majid, Md. Niamat Ali & Shahnaz Taing. (2020) Evaluation of T cell cytokines and their role in recurrent miscarriage. International Immunopharmacology 82, pages 106347.
Crossref
Crossref
Mark A.J. Koenis, Eveline H. Tiekink, Davita M.E. van Raamsdonk, Nadav U. Joosten, Susanne A. Gooijer, Valentin P. Nicu, Lucas Visscher & Wybren J. Buma. (2019) Analytical chemistry on many-center chiral compounds based on vibrational circular dichroism: Absolute configuration assignments and determination of contaminant levels. Analytica Chimica Acta 1090, pages 100-105.
Crossref
Crossref
Yu-Xia Jiang, Wen-Jun Shi, Dong-Dong Ma, Jin-Na Zhang, Guang-Guo Ying, Hui Zhang & Choon-Nam Ong. (2019) Dydrogesterone exposure induces zebrafish ovulation but leads to oocytes over-ripening: An integrated histological and metabolomics study. Environment International 128, pages 390-398.
Crossref
Crossref
R. V. Kapustin, O. N. Arzhanova & O. N. Bespalova. (2019) Exogenous progesterone as a factor for the development of gestational diabetes mellitus. Rossiiskii vestnik akushera-ginekologa 19:1, pages 38.
Crossref
Crossref
Hee Joong Lee, Errol Norwitz & Banghyun Lee. (2018) Relationship between threatened miscarriage and gestational diabetes mellitus. BMC Pregnancy and Childbirth 18:1.
Crossref
Crossref
M. V. UtrobinS. Yu. Yuryev. (2018) IMMUNOLOGICAL AND GENETIC CHANGES AS PREDICTORS IN THE LOSS OF PREGNANCY IN THE FORMATION OF RETROCHORIAL HEMATOMA IN THE FIRST TRIMESTER. Acta Biomedica Scientifica (East Siberian Biomedical Journal) 3:5, pages 9-15.
Crossref
Crossref
N. K. Tetruashvili & A. A. Agadzhanova. (2018) Dydrogesterone in the treatment of the threatened and habitual miscarriage. Medical Council:13, pages 68-72.
Crossref
Crossref
Helen Brown. (2018) Dydrogesterone: Shining New Light on Life. EMJ Reproductive Health, pages 51-57.
Crossref
Crossref
. 2017. High-Risk Pregnancy. High-Risk Pregnancy.
Stephanie Pildner von Steinburg, Ekkehard Schleußner, Ruben Kuon, Kilian Vomstein & Bettina Toth. 2018. Die Plazenta. Die Plazenta
221
245
.
Hee Joong Lee, Tae Chul Park, Jae Hoon Kim, Errol Norwitz & Banghyun Lee. (2017) The Influence of Oral Dydrogesterone and Vaginal Progesterone on Threatened Abortion: A Systematic Review and Meta-Analysis. BioMed Research International 2017, pages 1-10.
Crossref
Crossref
Thomas Strowitzki. 2017. Fehlgeburten Totgeburten Frühgeburten. Fehlgeburten Totgeburten Frühgeburten
111
118
.
Raj Raghupathy. (2016) Immunomodulation with progestogens as a therapeutic approach in pregnancy complications. Current Medicine Research and Practice 6:6, pages 233-239.
Crossref
Crossref
Adolf E. Schindler. (2016) Present and future aspects of dydrogesterone in prevention or treatment of pregnancy disorders: an outlook. Hormone Molecular Biology and Clinical Investigation 27:2, pages 49-53.
Crossref
Crossref
M. W. P. Barbosa, L. R. Silva, P. A. Navarro, R. A. Ferriani, C. O. Nastri & W. P. Martins. (2016)
Dydrogesterone
vs
progesterone for luteal-phase support: systematic review and meta-analysis of randomized controlled trials
. Ultrasound in Obstetrics & Gynecology 48:2, pages 161-170.
Crossref
Crossref
M. H. C. Craenmehr, S. Heidt, M. Eikmans & F. H. J. Claas. (2016) What is wrong with the regulatory T cells and foetomaternal tolerance in women with recurrent miscarriages?. HLA 87:2, pages 69-78.
Crossref
Crossref
Neta Benshalom-Tirosh, Dan Tirosh, Naama Steiner & Asher Bashiri. 2016. Recurrent Pregnancy Loss. Recurrent Pregnancy Loss
37
51
.
Asher Bashiri & Jamie L. Borick. 2016. Recurrent Pregnancy Loss. Recurrent Pregnancy Loss
3
18
.